Works by Graduates

 

Recent Submissions

  • First Do No Harm - The Indiana Providers Guide to the Safe, Effective Management of Chronic Non-Terminal Pain 
    Bell-Sharp, Kim; Gregory, Eigner; Brooks, Tracy L.; Elliott, Alicia; Cragen, Debbie; Ersin, Ozlem H.; Croasdell, Lori; Fernandes, Taya; Duwve, Joan; Fielding, Stephen M.; Gentry, Mark E.; Greene, Marion S.; King, Timothy E.; Kelley, Kristen; Konchalski, Jan; Kuzma, Abigail; LaHood, Amy; MacKie, Palmer J.; McMahan, Deborah; Mowry, James B.; Park, Esther J.; Pontones, Pam; Ring, Barry S.; Robinson, Natalie; Roth, Daniel C.; Rumsey, Todd C.; Schreier, Eric M.; Stone, Cynthia L.; Straub, Tom; Welch, Peggy; Sybesma, J. Michelle; Symmes, Shelly; Whitworth, Michael; Vaught, Cynthia; Weitlauf, Sharon L.; Weaver, Tamara; Zachodni, Carla (State of Indiana, 2013)
    "First Do No Harm: The Indiana Healthcare Providers Guide to the Safe, Effective Management of Chronic Non-Terminal Pain" was developed by the Indiana Prescription Drug Abuse Prevention Task Force’s Education Committee ...
  • Commercial Insurance Coverage Decline Associated with Affordable Care Act: What's Next? 
    Fielding, Stephen M.; Jerkins, David; Johnson, R. Michael (Ohio Valley Society of Plastic Surgeons, 2017-02-15)
    BACKGROUND: A key feature of the Affordable Care Act was the establishment of insurance exchanges and subsidies to assist Americans in obtaining affordable commercial insurance. This study was undertaken to determine whether ...
  • Effects of 12, 13 dibutyrate (PDBu) on resting and capsaicin-stimulated glutamate release in adult rat dorsal root neurons in culture 
    Richard, Joyce (2003-07-31)
    This investigation explored the role of PKC as an activator of VR1 through the use of capsaicin, a natural ligand for VR1, and the PKC activating phorbol ester 12,13 dibutyrate (PDBu). Direct effects of 30nM, 300nM, and ...